Decoy Therapeutics Inc. (DCOY) Net margin 2016–2021
Decoy Therapeutics Inc. (DCOY) net profit margin by fiscal year — reported net income divided by reported revenue.
-693.8%FY2021 · since FY2016: -3907.6% → -693.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -693.8% | -553.4 pp |
| FY2020 | -140.5% | +59.7 pp |
| FY2019 | -200.2% | -114.6 pp |
| FY2018 | -85.6% | +2616.2 pp |
| FY2017 | -2701.7% | +1205.9 pp |
| FY2016 | -3907.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net incomeDCOY Gross profitDCOY Gross marginDCOY Operating incomeDCOY Operating marginDCOY Operating cash flowDCOY Free cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Total liabilitiesDCOY Shareholders’ equityDCOY overview →